We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
-4%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.26B
AUM Growth
-$362M
Cap. Flow
-$5M
Cap. Flow %
-0.12%
Top 10 Hldgs %
43.71%
Holding
683
New
46
Increased
475
Reduced
93
Closed
17

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$38.3M
2
AMZN icon
Amazon
AMZN
+$27.7M
3
PLTR icon
Palantir
PLTR
+$17.5M
4
HIMS icon
Hims & Hers Health
HIMS
+$13.7M
5
YUMC icon
Yum China
YUMC
+$13.2M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$39.4M
2
NVDA icon
NVIDIA
NVDA
+$30.1M
3
META icon
Meta Platforms (Facebook)
META
+$14.9M
4
BEKE icon
KE Holdings
BEKE
+$14.1M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 42.45%
2 Consumer Discretionary 16.26%
3 Communication Services 14.17%
4 Healthcare 8.06%
5 Consumer Staples 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALMS
601
Alumis Inc
ALMS
$3.58B
$7.2K ﹤0.01%
1,172
+180
+18% +$1.05K
TKNO icon
602
Alpha Teknova
TKNO
$263M
$7.08K ﹤0.01%
1,365
+246
+22% +$1.82K
VNDA icon
603
Vanda Pharmaceuticals
VNDA
$303M
$6.85K ﹤0.01%
1,493
+269
+22% +$1.25K
PRME icon
604
Prime Medicine
PRME
$531M
$6.68K ﹤0.01%
3,358
+658
+24% +$1.68K
TECX
605
Tectonic Therapeutic
TECX
$524M
$6.68K ﹤0.01%
377
+67
+22% +$2.18K
AQST icon
606
Aquestive Therapeutics
AQST
$458M
$6.56K ﹤0.01%
2,262
+348
+18% +$1.05K
PSNL icon
607
Personalis
PSNL
$1.32B
$6.35K ﹤0.01%
1,809
+326
+22% +$1.55K
SLRN
608
DELISTED
ACELYRIN
SLRN
$6.34K ﹤0.01%
2,569
+462
+22% +$1.1K
TSVT
609
DELISTED
2seventy bio
TSVT
$6.32K ﹤0.01%
1,280
+197
+18% +$626
AVIR icon
610
Atea Pharmaceuticals
AVIR
$379M
$6.27K ﹤0.01%
2,096
+323
+18% +$1.01K
CBL
611
CBL Properties
CBL
$1.8B
$6.14K ﹤0.01%
231
+9
+4% +$264
AMLX icon
612
Amylyx Pharmaceuticals
AMLX
$2.18B
$6.02K ﹤0.01%
1,700
+261
+18% +$929
TERN
613
DELISTED
Terns Pharmaceuticals
TERN
$6K ﹤0.01%
2,174
+391
+22% +$1.6K
COIN icon
614
Coinbase
COIN
$37.1B
$5.86K ﹤0.01%
34
-11
-24% -$2.66K
IRWD icon
615
Ironwood Pharmaceuticals
IRWD
$685M
$5.84K ﹤0.01%
3,971
+611
+18% +$1.46K
HUMA icon
616
Humacyte
HUMA
$176M
$5.62K ﹤0.01%
3,295
+610
+23% +$2.29K
DSGN icon
617
Design Therapeutics
DSGN
$772M
$5.59K ﹤0.01%
1,449
+260
+22% +$1.24K
ITOS
618
DELISTED
iTeos Therapeutics
ITOS
$5.58K ﹤0.01%
935
+168
+22% +$1.23K
CDXS icon
619
Codexis
CDXS
$152M
$5.43K ﹤0.01%
2,019
+310
+18% +$1.2K
OLMA icon
620
Olema Pharmaceuticals
OLMA
$1.02B
$5.35K ﹤0.01%
1,422
+219
+18% +$1.1K
ANNX icon
621
Annexon
ANNX
$839M
$5.27K ﹤0.01%
2,729
+491
+22% +$1.63K
FHTX icon
622
Foghorn Therapeutics
FHTX
$263M
$5.2K ﹤0.01%
1,424
+257
+22% +$1.17K
CRVS icon
623
Corvus Pharmaceuticals
CRVS
$1.1B
$5.07K ﹤0.01%
1,594
+245
+18% +$1.15K
INBX icon
624
Inhibrx
INBX
$1.21B
$5.02K ﹤0.01%
359
+55
+18% +$747
YMAB
625
DELISTED
Y-mAbs Therapeutics
YMAB
$4.92K ﹤0.01%
1,111
+171
+18% +$993
23 24
25
26 27

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GF Fund Management's Q1 2025 Portfolio in Review

As of Q1 2025, GF Fund Management held 683 positions worth $4.26B, down 7.8% from $4.62B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

GF Fund Management's Q1 2025 filing shows 46 new, 475 increased, 93 reduced and 17 closed positions. Its largest new stake was Hims & Hers Health: 368,661 shares worth $10.9M. The largest sale was Pinduoduo, an estimated $39.4M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q1 2025 buy was Hims & Hers Health: 368,661 shares worth $10.9M.
  • GF Fund Management added most to Philip Morris in Q1 2025, an estimated $38.3M increase.
  • GF Fund Management's biggest Q1 2025 reduction was Pinduoduo, cutting an estimated $39.4M.
  • GF Fund Management fully exited Applied Optoelectronics in Q1 2025, selling an estimated $5.07M.
  • GF Fund Management's ten largest holdings make up 44% of its $4.26B portfolio in Q1 2025.
  • GF Fund Management opened 46 new positions and closed 17 in Q1 2025.
  • GF Fund Management's portfolio value fell 7.8% quarter-over-quarter to $4.26B.

Based on GF Fund Management's 13F filing for Q1 2025, filed 29 Apr 2025.